Evicita · Supplement evidence, graded and cited · Supplements · Lifestyle · Mechanisms · Lab tests · 中文

Scallop plasmalogens

Scallop-derived Purified Plasmalogens · also known as Plasmalogens, Scallop plasmalogens, Plasmalogens, Vinyl ether glycerophospholipids

Scallop plasmalogens have shown signs of antioxidant and neuroprotective activity in chemical and animal studies. The human trials on cognition are exploratory and in limited populations, so plasmalogens cannot be considered a proven treatment for mild cognitive impairment.

Typical dose: High-purity scallop plasmalogens 1–2 mg/day, taken with breakfast or lunch
Absorption and forms: Scallop plasmalogens come from the scallop mantle, and their vinyl ether bond is sensitive to oxidation. After oral intake they go through digestion and lipid remodeling, so there is no basis for claiming that the intact molecule reaches the brain directly.

Clinical uses and human evidence

Memory

Mixed resultsGrade B · Moderate evidence
Studies (2)
  1. Fukuchi 2026 · Front Nutr · RCT · n=68 — Orally administered scallop-derived plasmalogens improve cognitive function in healthy middle-aged and older adults: a randomized, double-blind, placebo-controlled trial
  2. Fujino 2017 · EBioMedicine · RCT · n=328 — Efficacy and Blood Plasmalogen Changes by Oral Administration of Plasmalogen in Patients with Mild Alzheimer's Disease and Mild Cognitive Impairment: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial

Attention and focus

Mixed resultsGrade B · Moderate evidence
Studies (2)
  1. Fukuchi 2026 · Front Nutr · RCT · n=68 — Orally administered scallop-derived plasmalogens improve cognitive function in healthy middle-aged and older adults: a randomized, double-blind, placebo-controlled trial
  2. Fujino 2022 · Front Cell Dev Biol · RCT · n=40 — Orally Administered Plasmalogens Alleviate Negative Mood States and Enhance Mental Concentration: A Randomized, Double-Blind, Placebo-Controlled Trial

Fatigue and energy

Mixed resultsGrade C · Preliminary evidence
Studies (1)
  1. Fujino 2022 · Front Cell Dev Biol · RCT · n=40 — Orally Administered Plasmalogens Alleviate Negative Mood States and Enhance Mental Concentration: A Randomized, Double-Blind, Placebo-Controlled Trial

Age-related cognitive decline

No benefitGrade B · Moderate evidence
Studies (1)
  1. Fujino 2017 · EBioMedicine · RCT · n=328 — Efficacy and Blood Plasmalogen Changes by Oral Administration of Plasmalogen in Patients with Mild Alzheimer's Disease and Mild Cognitive Impairment: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial

Mechanisms of action

Neurotrophic factor synthesis and TrkB/A receptor activation

★★★☆☆Mechanism evidence: grade CSecondary target

In mice, dietary plasmalogens can increase BDNF signaling in the hippocampus, and the related effects weakened when BDNF or TrkB was knocked down. In a 12-week human randomized trial, plasma BDNF did not differ significantly between groups, so the evidence for this neurotrophic pathway in humans is still limited.

References (2)
  1. Hossain et al. 2022 · Mouse study: dietary plasmalogens increased hippocampal BDNF signaling; the related effects were reduced after BDNF or TrkB knockdown
  2. Fukuchi et al. 2026 · Human randomized trial: no significant between-group difference in plasma BDNF at 12 weeks

Direct free radical trapping and chemical quenching

★★☆☆☆Mechanism evidence: grade DPrimary target

The vinyl ether bond of plasmalogens can react with oxidants or free radicals, and it acts as a sacrificial protector in chemical and membrane models. Whether it directly traps free radicals in humans, and whether 1–2 mg/day can achieve this in the brain, is currently unclear.

References (2)
  1. 2023 · Lipid chemistry experiment: the vinyl ether bond of plasmalogens can react with oxidants or free radicals
  2. 2022 · Mouse study: markers of oxidative damage improved after an oral scallop-derived preparation, but this alone cannot prove direct radical trapping

mTORC1 allosteric inhibition and macroautophagy induction

★☆☆☆☆Mechanism evidence: grade DSecondary target

Changes in amyloid pathology were seen in animal models, but this does not show that mTOR is inhibited or that lysosomal autophagy clears more β-amyloid. There are currently no reliable studies showing that routine oral scallop plasmalogens induce autophagy in humans.

References (2)
  1. 2022 · Mouse model: changes in amyloid pathology were observed, but this cannot establish mTOR inhibition or increased autophagic flux
  2. No direct study found in literature search · Conclusion: no reliable study shows that routine oral scallop plasmalogens induce mTOR-dependent autophagy in humans

Safety and drug interactions

Avoid scallop-derived products if you are allergic to shellfish or seafood. At usual doses, tolerability is generally good.
Open in the interactive app ›